224 related articles for article (PubMed ID: 16392608)
21. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
[TBL] [Abstract][Full Text] [Related]
22. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
[TBL] [Abstract][Full Text] [Related]
23. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
[TBL] [Abstract][Full Text] [Related]
24. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
[TBL] [Abstract][Full Text] [Related]
25. Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.
Nyman U; Ahlkvist J; Aspelin P; Brismar T; Frid A; Hellström M; Liss P; Sterner G; Leander P;
Eur Radiol; 2018 Dec; 28(12):5384-5395. PubMed ID: 30132106
[TBL] [Abstract][Full Text] [Related]
26. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention.
Nozue T; Michishita I; Iwaki T; Mizuguchi I; Miura M
J Cardiol; 2009 Oct; 54(2):214-20. PubMed ID: 19782258
[TBL] [Abstract][Full Text] [Related]
27. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
28. [Risk factors and prognosis of contrast-induced nephropathy with renal dysfunction].
Xu H; Chen LM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):232-6. PubMed ID: 15960272
[TBL] [Abstract][Full Text] [Related]
29. Minimizing contrast medium doses to diagnose pulmonary embolism with 80-kVp multidetector computed tomography in azotemic patients.
Holmquist F; Hansson K; Pasquariello F; Björk J; Nyman U
Acta Radiol; 2009 Mar; 50(2):181-93. PubMed ID: 19169917
[TBL] [Abstract][Full Text] [Related]
30. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
31. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.
Kim SM; Cha RH; Lee JP; Kim DK; Oh KH; Joo KW; Lim CS; Kim S; Kim YS
Am J Kidney Dis; 2010 Jun; 55(6):1018-25. PubMed ID: 20097462
[TBL] [Abstract][Full Text] [Related]
32. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.
Benko A; Fraser-Hill M; Magner P; Capusten B; Barrett B; Myers A; Owen RJ;
Can Assoc Radiol J; 2007 Apr; 58(2):79-87. PubMed ID: 17521052
[TBL] [Abstract][Full Text] [Related]
33. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
[TBL] [Abstract][Full Text] [Related]
34. Renal assessment using CKD-EPI equation is useful as an early predictor of contrast- induced nephropathy in elderly patients with cancer.
Park SY; Lee KW
J Geriatr Oncol; 2017 Jan; 8(1):44-49. PubMed ID: 27491499
[TBL] [Abstract][Full Text] [Related]
35. Lower blood vitamin D levels are associated with an increased incidence of contrast-induced nephropathy in patients undergoing coronary angiography.
Sahin I; Gungor B; Can MM; Avci II; Guler GB; Okuyan E; Biter H; Yildiz SS; Ayca B; Satilmis S; Dinckal MH
Can J Cardiol; 2014 Apr; 30(4):428-33. PubMed ID: 24680172
[TBL] [Abstract][Full Text] [Related]
36. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
37. Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case series.
Komenda P; Zalunardo N; Burnett S; Love J; Buller C; Taylor P; Duncan J; Djurdjev O; Levin A
Clin Exp Nephrol; 2007 Sep; 11(3):209-213. PubMed ID: 17891347
[TBL] [Abstract][Full Text] [Related]
38. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Slocum NK; Grossman PM; Moscucci M; Smith DE; Aronow HD; Dixon SR; Share D; Gurm HS
Am Heart J; 2012 May; 163(5):829-34. PubMed ID: 22607861
[TBL] [Abstract][Full Text] [Related]
39. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
[TBL] [Abstract][Full Text] [Related]
40. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
